ווטריינט 400 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

PAZOPANIB AS HYDROCHLORIDE 400 MG

Dostupné s:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kód:

L01XE11

Léková forma:

FILM COATED TABLETS

Podání:

PER OS

Výrobce:

GLAXO OPERATIONS UK LIMITED

Terapeutické skupiny:

PAZOPANIB

Terapeutické indikace:

Renal cell carcinoma (RCC)Votrient is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.Soft tissue sarcoma (STS)Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

Datum autorizace:

2011-01-01